Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye.
BERWYN, Pa.--(BUSINESS WIRE)--Nordic Pharma, Inc. has launched LACRIFILL® Canalicular Gel, a novel therapy for dry eye in the U.S.